| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 research v0.36 | LAMTOR2 |
Ellen McDonagh gene: LAMTOR2 was added gene: LAMTOR2 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: LAMTOR2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: LAMTOR2 were set to 22427693; 17195838; 24092934; 28593997 Phenotypes for gene: LAMTOR2 were set to Neutropenia, Hypogammaglobulinemia CD8 cytotoxicity, partial albinism, growth failure; Congenital neutropenia; Congenital defects of phagocyte number or function; Primary immunodeficiency syndrome due to p14 deficiency; Immunodeficiency due to defect in MAPBP-interacting protein, 610798 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||